LOGIN  |  REGISTER
Viking Therapeutics
Cue Biopharma

Tenet Healthcare Names CEO Saum Sutaria as Chairman of the Board

August 10, 2023 | Last Trade: US$193.35 1.67 -0.86

DALLAS / Aug 10, 2023 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022.

Sutaria has served as Tenet Healthcare’s CEO since September 2021 and a member of the Board of Directors since 2020. Previously, he served as the Company’s Chief Operating Officer.

“The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare,” said Senator J. Robert Kerrey, Lead Director. “The Board looks forward to working closely with him in this new capacity to continue to create value for all our stakeholders.”

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 475 ambulatory surgery centers and surgical hospitals. We also operate 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.

C4 Therapeutics

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page